Cargando…
GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer
The emergence of targeted cancer therapy has been limited by the paucity of determinants which are tumor-specific and generally associated with disease, and have cell dynamics which effectively deploy cytotoxic payloads. Guanylyl cyclase C (GUCY2C) may be ideal for targeting because it is normally e...
Autores principales: | Marszalowicz, Glen P., Snook, Adam E., Magee, Michael S., Merlino, Dante, Lisa, D. Berman-Booty, Waldman, Scott A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253446/ https://www.ncbi.nlm.nih.gov/pubmed/25294806 |
Ejemplares similares
-
GUCY2C-targeted chimeric antigen receptor expressing T cells extend survival in a therapeutic mouse model of metastatic colorectal cancer
por: Magee, Michael S, et al.
Publicado: (2013) -
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
por: Magee, Michael S., et al.
Publicado: (2016) -
GUCY2C at the intersection of obesity and colorectal cancer
por: Waldman, Scott A, et al.
Publicado: (2013) -
Hormone suppression silencing GUCY2C is required for colorectal cancer
por: Waldman, Scott A
Publicado: (2015) -
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
por: Cheslow, Lara, et al.
Publicado: (2023)